# Vision II: Evaluation of GALILEO Intravascular Radiotherapy System

> **NCT00180583** · PHASE4 · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 268 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Guidant GALILEO Intravascular Radiotherapy System

## Key facts

- **NCT ID:** NCT00180583
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 268 (ACTUAL)
- **Last updated:** 2008-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00180583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00180583, "Vision II: Evaluation of GALILEO Intravascular Radiotherapy System". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00180583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*